Basic information Safety Supplier Related
ChemicalBook >  Product Catalog >  Organic Chemistry >  Amides >  Amides >  N-methyl-2-(4-methylpiperazin-1-yl)-N-(4-nitrophenyl)acetamide

N-methyl-2-(4-methylpiperazin-1-yl)-N-(4-nitrophenyl)acetamide

Basic information Safety Supplier Related

N-methyl-2-(4-methylpiperazin-1-yl)-N-(4-nitrophenyl)acetamide Basic information

Product Name:
N-methyl-2-(4-methylpiperazin-1-yl)-N-(4-nitrophenyl)acetamide
Synonyms:
  • Nidanib Impurity 12: N-methyl-2- (4-methylpiperazin-1-yl) -N- (4-nitrophenyl) -acetamide
  • N-Methyl-2-(4-methyl-1-piperazinyl)-N-(4-nitrophenyl)acetamide
  • N-methyl-2-(4-methylpiperazin-1-yl)-N-(4-nitrophenyl)acetamide
  • N,4-Dimethyl-N-(4-nitrophenyl)-1-piperazineacetamide
  • Nintedanib impurity 2/N-methyl-2-(4-methylpiperazin-1-yl)-N-(4-nitrophenyl)acetamide
  • Nintedanib Intermediate 1
  • Intedanib Impurity 12
  • Nintedanib-003
CAS:
1139453-98-7
MF:
C14H20N4O3
MW:
292.33
Product Categories:
  • Intermediate of BIBF-1120 and PKI587
Mol File:
1139453-98-7.mol
More
Less

N-methyl-2-(4-methylpiperazin-1-yl)-N-(4-nitrophenyl)acetamide Chemical Properties

Melting point:
94 - 96°C
Boiling point:
446.9±40.0 °C(Predicted)
Density 
1.230
storage temp. 
2-8°C
solubility 
DMSO (Slightly), Methanol (Slightly)
pka
7.43±0.10(Predicted)
form 
Solid
color 
Pale Yellow to Light Yellow
More
Less

N-methyl-2-(4-methylpiperazin-1-yl)-N-(4-nitrophenyl)acetamide Usage And Synthesis

Uses

N-Methyl-2-(4-methylpiperazin-1-yl)-N-(4-nitrophenyl)acetamide is used as a reactant in the synthetic preparation of 6-methoxycarbonyl-substituted indolinones, such as Intedanib (I666650), which is a triple angiokinase inhibitor and antitumor agent.

Synthesis

109-01-3

2653-16-9

1139453-98-7

General procedure for the synthesis of N-methyl-2-(4-methylpiperazin-1-yl)-N-(4-nitrophenyl)acetamide from N-methylpiperazine and 2-chloro-N-methyl-N-(4-nitrophenyl)acetamide: 1-methylpiperazine (7.2 mL, 65 mmol) and potassium carbonate (13.8 g, 100 mmol) were dissolved in acetone (200 mL) and subsequently 2-chloro-N-methyl-N-(4-nitrophenyl)acetamide (11.4 g, 50 mmol) was added slowly. The reaction mixture was stirred at room temperature for 12 hours. After completion of the reaction, the precipitate was removed by filtration and the filtrate was rotary evaporated to remove the solvent. The residue was dissolved in ethyl acetate (50 mL × 3) and extracted with 20 mL of water. The organic phase was dried with anhydrous sodium sulfate and concentrated under reduced pressure to remove the solvent to give 15 g of the target compound. LC-MS analysis showed m/z = 293 ([M+H]+).

References

[1] Patent: WO2009/71524, 2009, A2. Location in patent: Page/Page column 21-22; 13
[2] Patent: WO2009/71524, 2009, A2. Location in patent: Page/Page column 21-22; 13
[3] Patent: WO2009/71523, 2009, A1. Location in patent: Page/Page column 4; 23-24
[4] Patent: WO2009/71523, 2009, A1. Location in patent: Page/Page column 4; 24
[5] Journal of Labelled Compounds and Radiopharmaceuticals, 2015, vol. 58, # 7, p. 308 - 312

N-methyl-2-(4-methylpiperazin-1-yl)-N-(4-nitrophenyl)acetamideSupplier

BeiJing Hwrk Chemicals Limted
Tel
0757-86329057 18934348241
Email
sales4.gd@hwrkchemical.com
Adamas Reagent, Ltd.
Tel
400-6009262 16621234537
Email
chenyj@titansci.com
Jinan Trio PharmaTech Co., Ltd.
Tel
0531-88811783
Email
sales@trio-pharmatech.com
Chengdu D-innovation Pharmaceutical Co.,LTD
Tel
028-85105512 17802830247
Email
baozuqiang@d-innovation.com
Syncozymes (Shanghai) Co.,Ltd.
Tel
021-68187180 13681683526
Email
lchen@syncozymes.com